Related Experiment Video
Updated: Jul 6, 2026

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
Published on: September 28, 2022
Epstein-Barr virus related lymphoma in inflammatory bowel disease
S Van Biervliet1, S Vande Velde, R De Bruyne
1Paediatric gastroenterology Unit, University Hospital Ghent, Ghent, Belgium. stephanie.vanbiervliet@ugent.be
Insights
Epstein-Barr virus (EBV) lymphoproliferative disease is a risk for children with inflammatory bowel disease (IBD) on immunosuppressants. Close monitoring of EBV status is crucial for these young patients.
Area of Science:
- Pediatric Gastroenterology
- Immunology
- Hematology Oncology
Background:
- Epstein-Barr virus (EBV) lymphoproliferative disease is a known risk in immunocompromised children, particularly post-transplant.
- The rising incidence of pediatric inflammatory bowel disease (IBD) leads to increased use of immunomodulatory agents in EBV-naive children.
- The risk of EBV-related lymphoproliferative disease in young IBD patients treated with immunosuppressants is not well-defined.
Observation:
- A young patient with Crohn's disease (CD) developed an EBV-related lymphoma.
- The lymphoma occurred shortly after EBV primo-infection.
- The patient was undergoing treatment with azathioprine, an immunosuppressive drug.
Findings:
- This case highlights a potential risk of EBV-induced lymphoproliferative disease in young IBD patients on immunosuppressive therapy.
- The development of lymphoma suggests that EBV primo-infection can trigger significant complications in this population.
Implications:
- Young IBD patients treated with immunosuppressive drugs require rigorous monitoring for EBV status.
- Early detection and management of EBV complications are essential in this vulnerable pediatric population.
- Further research is needed to compare the risk and evolution of EBV-related lymphoproliferative disease in IBD patients versus transplanted patients.
Abstract:
Epstein-Barr virus (EBV) induced lymphoproliferative disease is a well-known, feared complication of EBV primo-infection in children treated with immunomodulators or immunosuppressive drugs, eg after transplantation. As the incidence of inflammatory bowel disease (IBD) in young children is rising, more young EBV naive patients are treated with immunomodulatory agents. It is not yet clear whether these patients carry the same risk as transplanted patients to develop lymphoproliferative disease and if so, whether their evolution is comparable. We present the history of a young patient with Crohn's disease who developed an EBV related lymphoma shortly after the primo-infection while being treated with azathioprine. This case argues for a rigorous follow up of young IBD patients treated with immune suppressive drugs, also regarding EBV status.
More Related Videos
08:44Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
09:43An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease IV: Clinical Manifestations